Study On Growth Of Listed Companies In Medical Industry

Growth is a soul of the company, is a life of the stock, is a main drive power of the sustained development for national economy, and is a key index as well of evaluation business situation and prospect of the listed company. The Chinese stock markets are gradually turning to a standard way through more than ten years' development. The stock theory research in stock market's development sets forth lots new issues which are still waiting for answers, basic one of them is the evaluation for investment of the listed company, analyzing Growth of enterprise is considered quite important while evaluating the investment value for the stock.Growth is a common issue concerned by the relative benefits parties, such as company governor and investor, and is the future worthiness of company. Growth is becoming a focus core in the theories' study since it is one of goals pursued by company. Growth is an integration character representing in various respects, i.e. in business management and development trend. Analysis from finance angle, a growing company should have the characters including the reasonable capital structure, having strength and enlarging scale gradually every year in same line, controlling the cost effectively, having sturdy competition, achieving good performance steadily in future business and so on.On the base of integrating other research, this thesis is to structure a evaluation's mode for the listed company's growth of Chinese medicine field by financial reports, analyze the growth primarily of the medicine listed company by using PCA from the aspect of finance, and provide valuable reference both for enterprise governor and investor, thus, it could benefit to drive the company developing in medicine industry and expand prospect of product. Meanwhile, it could help to enlarge the company scale gradually per year and promote the increase trend of business profit.